Provided by Tiger Trade Technology Pte. Ltd.

Century Therapeutics, Inc.

2.03
-0.0400-1.93%
Volume:293.08K
Turnover:598.60K
Market Cap:367.43M
PE:-2.18
High:2.10
Open:2.07
Low:2.03
Close:2.07
52wk High:3.04
52wk Low:0.4350
Shares:181.00M
Float Shares:101.00M
Volume Ratio:0.88
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-0.1107
ROE:-49.65%
ROA:-23.51%
PB:1.58
PE(LYR):-18.34

Loading ...

Century Therapeutics Adds Director, Advances Cell Therapy Pipeline

TIPRANKS
·
13 hours ago

Century Therapeutics - Increases Board Size to Seven Directors, Appoints Joseph Truitt Effective Sept 9, 2026 - SEC Filing

THOMSON REUTERS
·
13 hours ago

Century Therapeutics Appoints Joseph Truitt to Board of Directors

THOMSON REUTERS
·
13 hours ago

Century Therapeutics (IPSC) Gets a Buy from Mizuho Securities

TIPRANKS
·
Aug 18

Phil Nadeau Initiates Buy on Century Therapeutics, Citing Promising T1D Program, Advancing Pipeline, and Strong Cash Runway

TIPRANKS
·
Aug 13

Century Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

MiNK Therapeutics Q2 Loss Narrows on Expense Discipline

Reuters
·
Aug 13

Abeona Therapeutics Q2 Net Loss Widens, Misses Analyst Expectations

Reuters
·
Aug 13

Clear Street Sticks to Its Buy Rating for Century Therapeutics (IPSC)

TIPRANKS
·
Aug 13

Century Therapeutics Reports Q2 Results, Pipeline Advancements

TIPRANKS
·
Aug 12

Century Therapeutics Q2 Net Loss Misses Estimates on Lease Termination Loss

Reuters
·
Aug 12

Century Therapeutics Q2 EPS $(0.17) Misses $(0.14) Estimate

Benzinga Earnings
·
Aug 12

Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million

Reuters
·
Aug 12

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

THOMSON REUTERS
·
Aug 12

Century Therapeutics Q2 Operating Expenses USD 36.527 Million

THOMSON REUTERS
·
Aug 12

Century Therapeutics Q2 Basic EPS USD -0.17

THOMSON REUTERS
·
Aug 12

Century Therapeutics, Inc. Expected to Post a Loss of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Century Therapeutics Inc Expected to Post a Loss of 11 Cents a Share - Earnings Preview

Reuters
·
Jul 31

Will Century Therapeutics (NASDAQ:IPSC) Spend Its Cash Wisely?

Simply Wall St.
·
Jul 16

Century Therapeutics to Present Cnty-813 Type 1 Diabetes Preclinical Data at EASD 2026

Reuters
·
Jul 09